Evommune, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
EVMN
Evommune, INCEvommune, Inc. has issued a proxy statement announcing its 2026 Annual Meeting of Stockholders, scheduled for June 2, 2026, to elect directors and ratify auditor appointments.